Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
Multi-objective fluorescent molecule design with a data-physics dual-driven generative framework
arXiv:2601.13564v1 Announce Type: cross Abstract: Designing fluorescent small molecules with tailored optical and physicochemical properties requires navigating vast, underexplored chemical space while satisfying multiple objectives and constraints. Conventional generate-score-screen approaches become impractical under such realistic design specifications, owing to their low search efficiency, unreliable generalizability of machine-learning prediction, and the prohibitive cost of quantum chemic
-
cs.AI, q-bio.NC updates on arXiv.org
-
Data-Chain Backdoor: Do You Trust Diffusion Models as Generative Data Supplier?
arXiv:2512.15769v1 Announce Type: cross Abstract: The increasing use of generative models such as diffusion models for synthetic data augmentation has greatly reduced the cost of data collection and labeling in downstream perception tasks. However, this new data source paradigm may introduce important security concerns. This work investigates backdoor propagation in such emerging generative data supply chains, namely Data-Chain Backdoor (DCB). Specifically, we find that open-source diffusion mo
Data-Chain Backdoor: Do You Trust Diffusion Models as Generative Data Supplier?
-
npj Digital Medicine
-
AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential
npj Digital Medicine, Published online: 11 December 2025; doi:10.1038/s41746-025-02198-6AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential
AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential
npj Digital Medicine, Published online: 11 December 2025; doi:10.1038/s41746-025-02198-6
AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential-
cs.AI, q-bio.NC updates on arXiv.org
-
KidSpeak: A General Multi-purpose LLM for Kids' Speech Recognition and Screening
arXiv:2512.05994v1 Announce Type: cross Abstract: With the rapid advancement of conversational and diffusion-based AI, there is a growing adoption of AI in educational services, ranging from grading and assessment tools to personalized learning systems that provide targeted support for students. However, this adaptability has yet to fully extend to the domain of children's speech, where existing models often fail due to their reliance on datasets designed for clear, articulate adult speech. Chi
KidSpeak: A General Multi-purpose LLM for Kids' Speech Recognition and Screening
-
cs.AI, q-bio.NC updates on arXiv.org
-
AI Deception: Risks, Dynamics, and Controls
arXiv:2511.22619v2 Announce Type: replace Abstract: As intelligence increases, so does its shadow. AI deception, in which systems induce false beliefs to secure self-beneficial outcomes, has evolved from a speculative concern to an empirically demonstrated risk across language models, AI agents, and emerging frontier systems. This project provides a comprehensive and up-to-date overview of the AI deception field, covering its core concepts, methodologies, genesis, and potential mitigations. Fir
AI Deception: Risks, Dynamics, and Controls
-
cs.AI, q-bio.NC updates on arXiv.org
-
MedCondDiff: Lightweight, Robust, Semantically Guided Diffusion for Medical Image Segmentation
arXiv:2512.00350v1 Announce Type: cross Abstract: We introduce MedCondDiff, a diffusion-based framework for multi-organ medical image segmentation that is efficient and anatomically grounded. The model conditions the denoising process on semantic priors extracted by a Pyramid Vision Transformer (PVT) backbone, yielding a semantically guided and lightweight diffusion architecture. This design improves robustness while reducing both inference time and VRAM usage compared to conventional diffusion
MedCondDiff: Lightweight, Robust, Semantically Guided Diffusion for Medical Image Segmentation
-
cs.AI, q-bio.NC updates on arXiv.org
-
Life-Code: Central Dogma Modeling with Multi-Omics Sequence Unification
arXiv:2502.07299v3 Announce Type: replace-cross Abstract: The interactions between DNA, RNA, and proteins are fundamental to biological processes, as illustrated by the central dogma of molecular biology. Although modern biological pre-trained models have achieved great success in analyzing these macromolecules individually, their interconnected nature remains underexplored. This paper follows the guidance of the central dogma to redesign both the data and model pipeline and offers a comprehens
Life-Code: Central Dogma Modeling with Multi-Omics Sequence Unification
-
cs.AI, q-bio.NC updates on arXiv.org
-
Rethinking Bias in Generative Data Augmentation for Medical AI: a Frequency Recalibration Method
arXiv:2511.12301v1 Announce Type: cross Abstract: Developing Medical AI relies on large datasets and easily suffers from data scarcity. Generative data augmentation (GDA) using AI generative models offers a solution to synthesize realistic medical images. However, the bias in GDA is often underestimated in medical domains, with concerns about the risk of introducing detrimental features generated by AI and harming downstream tasks. This paper identifies the frequency misalignment between real a
Rethinking Bias in Generative Data Augmentation for Medical AI: a Frequency Recalibration Method
-
cs.AI, q-bio.NC updates on arXiv.org
-
From Efficiency to Adaptivity: A Deeper Look at Adaptive Reasoning in Large Language Models
arXiv:2511.10788v1 Announce Type: new Abstract: Recent advances in large language models (LLMs) have made reasoning a central benchmark for evaluating intelligence. While prior surveys focus on efficiency by examining how to shorten reasoning chains or reduce computation, this view overlooks a fundamental challenge: current LLMs apply uniform reasoning strategies regardless of task complexity, generating long traces for trivial problems while failing to extend reasoning for difficult tasks. Thi
From Efficiency to Adaptivity: A Deeper Look at Adaptive Reasoning in Large Language Models
-
cs.AI, q-bio.NC updates on arXiv.org
-
A Survey on Cache Methods in Diffusion Models: Toward Efficient Multi-Modal Generation
arXiv:2510.19755v3 Announce Type: replace-cross Abstract: Diffusion Models have become a cornerstone of modern generative AI for their exceptional generation quality and controllability. However, their inherent \textit{multi-step iterations} and \textit{complex backbone networks} lead to prohibitive computational overhead and generation latency, forming a major bottleneck for real-time applications. Although existing acceleration techniques have made progress, they still face challenges such as
A Survey on Cache Methods in Diffusion Models: Toward Efficient Multi-Modal Generation
-
cs.AI, q-bio.NC updates on arXiv.org
-
BALR-SAM: Boundary-Aware Low-Rank Adaptation of SAM for Resource-Efficient Medical Image Segmentation
arXiv:2509.24204v2 Announce Type: replace-cross Abstract: Vision foundation models like the Segment Anything Model (SAM), pretrained on large-scale natural image datasets, often struggle in medical image segmentation due to a lack of domain-specific adaptation. In clinical practice, fine-tuning such models efficiently for medical downstream tasks with minimal resource demands, while maintaining strong performance, is challenging. To address these issues, we propose BALR-SAM, a boundary-aware lo
BALR-SAM: Boundary-Aware Low-Rank Adaptation of SAM for Resource-Efficient Medical Image Segmentation
-
Omics In Lung
-
Prospective proteomics for discovering biomarkers in lung adenocarcinoma: a literature review
Transl Cancer Res. 2025 Sep 30;14(9):6102-6117. doi: 10.21037/tcr-2025-1092. Epub 2025 Sep 26.ABSTRACTBACKGROUND AND OBJECTIVE: Lung adenocarcinoma (LUAD), as the main subtype of non-small cell lung cancer (NSCLC), faces clinical challenges including molecular heterogeneity, late diagnosis, and aggressive growth, leading to a low 5-year survival rate. Biomarkers are critical for early detection, accurate differentiation of benign/malignant lesions, and guiding personalized treatment strategies.
Prospective proteomics for discovering biomarkers in lung adenocarcinoma: a literature review
Transl Cancer Res. 2025 Sep 30;14(9):6102-6117. doi: 10.21037/tcr-2025-1092. Epub 2025 Sep 26.
ABSTRACT
BACKGROUND AND OBJECTIVE: Lung adenocarcinoma (LUAD), as the main subtype of non-small cell lung cancer (NSCLC), faces clinical challenges including molecular heterogeneity, late diagnosis, and aggressive growth, leading to a low 5-year survival rate. Biomarkers are critical for early detection, accurate differentiation of benign/malignant lesions, and guiding personalized treatment strategies. Proteomic technologies using liquid biopsy show potential by analyzing protein changes and post-translational modifications (PTMs) to identify novel biomarkers and unravel cancer mechanisms. This review examines proteomic advances in LUAD, compares platform strengths, lists validated protein markers, and discusses challenges like specificity and regulations. It aims to develop a precision medicine framework by integrating multi-omics data for improved diagnosis and treatment.
METHODS: This study conducted a literature review by searching the PubMed and Web of Science databases for original articles written in English from 2002 to 2025, using the keywords "lung adenocarcinoma" OR "LUAD" AND "biomarkers" AND "proteomics" OR "SomaScan" OR "spatial proteomics" to identify the latest research findings in the field of proteomics technology and LUAD biomarkers. The included studies mainly focused on the current landscape of biomarkers in the diagnosis, treatment, and prognosis of LUAD.
KEY CONTENT AND FINDINGS: This review discusses high-throughput methods for comprehensive protein profiling in accessible biospecimens (tissues, blood, urine) to identify biomarkers for LUAD. We systematically evaluate emerging proteomic strategies, including mass spectrometry (MS), proximity extension assays (PEAs), spatial proteomics techniques, and SomaScan platforms-coupled with innovative computational frameworks have revolutionized biomarkers discovery and their translational potential in developing precision diagnostics and targeted therapies. Additionally, the review addresses challenges in integrating proteomics with genomics, transcriptomics, and metabolomics, offering new methodologies and expanding research in life sciences. As technological advancements continue, it is anticipated that more potential biomarkers will be conducted to validate the broader application in LUAD treatment, addressing early-stage disease complexities and aiding in selecting more effective treatment strategies.
CONCLUSIONS: By synthesizing cutting-edge evidence on proteome-driven LUAD biomarkers, this review elucidates actionable strategies to refine early detection protocols and mechanism-informed personalized treatment frameworks, directly advancing precision oncology initiatives for this prevalent malignancy through biomarker-guided clinical decision-making and multi-omics integration.
PMID:41158224 | PMC:PMC12554480 | DOI:10.21037/tcr-2025-1092
-
(Multiomics OR Omics) AND (Pancreatic)
-
Multi-omics analyses inform mechanisms of immunotherapy response in pancreatic cancer
Front Immunol. 2025 Oct 2;16:1673098. doi: 10.3389/fimmu.2025.1673098. eCollection 2025.ABSTRACTINTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) continues to exhibit resistance to immunotherapy. In this study, we evaluated the efficacy of combining immunotherapy with chemotherapy for the treatment of advanced pancreatic cancer. Additionally, we employed a multimodal analytical approach to elucidate the immune landscape and conduct transcriptomic profiling in PDAC.METHODS: A retrospective an
Multi-omics analyses inform mechanisms of immunotherapy response in pancreatic cancer
Front Immunol. 2025 Oct 2;16:1673098. doi: 10.3389/fimmu.2025.1673098. eCollection 2025.
ABSTRACT
INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) continues to exhibit resistance to immunotherapy. In this study, we evaluated the efficacy of combining immunotherapy with chemotherapy for the treatment of advanced pancreatic cancer. Additionally, we employed a multimodal analytical approach to elucidate the immune landscape and conduct transcriptomic profiling in PDAC.
METHODS: A retrospective analysis was conducted on the clinical data of 52 patients diagnosed with advanced PDAC who underwent a combined treatment regimen of immunotherapy and chemotherapy. The study evaluated the objective response rate (ORR), disease control rate (DCR), and progression-free survival (PFS). To characterize the immune landscape in treatment-naive pancreatic ductal adenocarcinoma (PDAC) tumors and in the systemic circulation, flow cytometry, multiplex immunohistochemistry (mIHC), and whole transcriptome sequencing were employed.
RESULTS: The study reported an ORR of 32.7%, a DCR of 67.3%, and a 6-month PFS rate of 38.5%, with a median PFS of 5.5 months. Patients treated with a combination of immunotherapy and gemcitabine achieved the longest PFS. The first-line treatment cohort exhibited a significantly higher DCR (79.3% vs. 52.2%, P = 0.038) and a longer median PFS (6.6 vs. 3.5 months, P = 0.032) compared to the second-line treatment cohort. The efficacy of treatment varied depending on the drug combinations used. Flow cytometry analysis revealed a greater frequency of CD45- CD64+ cells in the peripheral blood of patients with progressive disease (PD) compared to those with a partial response (PR). Multiplex immunofluorescence (MIF) analysis indicated an increased intratumoral infiltration of CD8+ T cells and CD137+ CD8+ T cells in patients with PR. Whole transcriptome sequencing (WTSS) identified key genes involved in immune regulation, signal transduction, and digestive function. Hemopexin (HPX) and regulatory factor X-associated protein (RFXAP) were upregulated in PR patients and showed a positive correlation with survival, whereas Interleukin-6 (IL-6) expression was linked to poor prognosis.
CONCLUSIONS: These findings indicate that immunochemotherapy shows potential for the treatment of advanced PDAC. Our study elucidates the immune landscape associated with PDAC and provides critical insights for the identification of prospective therapeutic targets, which could guide the development of innovative combination immunotherapy strategies.
PMID:41112307 | PMC:PMC12528169 | DOI:10.3389/fimmu.2025.1673098
-
Nature - Issue - nature.com science feeds
-
AI chatbots are already biasing research — we must establish guidelines for their use now
Nature, Published online: 09 September 2025; doi:10.1038/d41586-025-02810-5The academic community has looked at how artificial-intelligence tools help researchers to write papers, but not how they distort the literature scientists choose to cite.
AI chatbots are already biasing research — we must establish guidelines for their use now
Nature, Published online: 09 September 2025; doi:10.1038/d41586-025-02810-5
The academic community has looked at how artificial-intelligence tools help researchers to write papers, but not how they distort the literature scientists choose to cite.-
(Multiomics OR Omics) AND (Pancreatic)
-
New advances in oral microbiology and tumor research
World J Clin Oncol. 2025 Jul 24;16(7):106981. doi: 10.5306/wjco.v16.i7.106981.ABSTRACTCancer remains a major global health concern, with escalating incidence and mortality rates underscoring the urgent need for novel diagnostic and therapeutic strategies. Increasing evidence has identified the oral microbiota as a critical contributor to tumorigenesis, thereby expanding the understanding of cancer pathogenesis beyond conventional risk factors such as tobacco use and genetic predisposition. This
New advances in oral microbiology and tumor research
World J Clin Oncol. 2025 Jul 24;16(7):106981. doi: 10.5306/wjco.v16.i7.106981.
ABSTRACT
Cancer remains a major global health concern, with escalating incidence and mortality rates underscoring the urgent need for novel diagnostic and therapeutic strategies. Increasing evidence has identified the oral microbiota as a critical contributor to tumorigenesis, thereby expanding the understanding of cancer pathogenesis beyond conventional risk factors such as tobacco use and genetic predisposition. This review summarizes recent progress in elucidating the complex relationship between the oral microbiota and various malignancies, particularly oral squamous cell carcinoma, esophageal adenocarcinoma, and pancreatic ductal adenocarcinoma. Pathogenic bacteria, including Porphyromonas gingivalis and Fusobacterium nucleatum, have been implicated in promoting tumor progression through mechanisms involving chronic inflammation, the production of metabolic toxins, and immune evasion. The dysbiosis of the oral microbiota, often driven by lifestyle factors such as poor diet, tobacco use, and alcohol consumption, further exacerbates these carcinogenic processes. Emerging therapeutic approaches including probiotics, oral microbiota transplantation, and CRISPR-based bacterial editing are under investigation for their potential to restore microbial homeostasis and suppress pathogenic species. Additionally, saliva-based microbial biomarkers have shown promise for non-invasive cancer screening. The integration of multi-omics technologies and artificial intelligence-driven platforms is further advancing the development of precision oncology. This review aims to consolidate fragmented findings concerning the oral microbiota-cancer axis and address existing gaps in mechanistic understanding. The review's significance lies in the translational potential of microbial research to clinical applications, offering opportunities to reduce the global cancer burden through early detection and microbiota-targeted therapies.
PMID:40741186 | PMC:PMC12304933 | DOI:10.5306/wjco.v16.i7.106981
-
Nature - Issue - nature.com science feeds
-
Complex genetic variation in nearly complete human genomes
Nature, Published online: 23 July 2025; doi:10.1038/s41586-025-09140-6Using sequencing and haplotype-resolved assembly of 65 diverse human genomes, complex regions including the major histocompatibility complex and centromeres are analysed.
Complex genetic variation in nearly complete human genomes
Nature, Published online: 23 July 2025; doi:10.1038/s41586-025-09140-6
Using sequencing and haplotype-resolved assembly of 65 diverse human genomes, complex regions including the major histocompatibility complex and centromeres are analysed.-
Nature - Issue - nature.com science feeds
-
The Somatic Mosaicism across Human Tissues Network
Nature, Published online: 02 July 2025; doi:10.1038/s41586-025-09096-7The Somatic Mosaicism across Human Tissues Network aims to create a reference catalogue of somatic mosaicism across different tissues and cells within individuals.
The Somatic Mosaicism across Human Tissues Network
Nature, Published online: 02 July 2025; doi:10.1038/s41586-025-09096-7
The Somatic Mosaicism across Human Tissues Network aims to create a reference catalogue of somatic mosaicism across different tissues and cells within individuals.-
Nature Biotechnology - Issue - nature.com science feeds
-
A call for built-in biosecurity safeguards for generative AI tools
Nature Biotechnology, Published online: 28 April 2025; doi:10.1038/s41587-025-02650-8A call for built-in biosecurity safeguards for generative AI tools
A call for built-in biosecurity safeguards for generative AI tools
Nature Biotechnology, Published online: 28 April 2025; doi:10.1038/s41587-025-02650-8
A call for built-in biosecurity safeguards for generative AI tools-
Nature - Issue - nature.com science feeds
-
Author Correction: π-HuB: the proteomic navigator of the human body
Nature, Published online: 23 December 2024; doi:10.1038/s41586-024-08555-xAuthor Correction: π-HuB: the proteomic navigator of the human body
Author Correction: π-HuB: the proteomic navigator of the human body
Nature, Published online: 23 December 2024; doi:10.1038/s41586-024-08555-x
Author Correction: π-HuB: the proteomic navigator of the human body-
Cell Death Discovery nature.com science feeds
-
Ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer: a comparative bibliometric analysis
Cell Death Discovery, Published online: 10 July 2023; doi:10.1038/s41420-023-01542-7Ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer: a comparative bibliometric analysis
Ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer: a comparative bibliometric analysis
Cell Death Discovery, Published online: 10 July 2023; doi:10.1038/s41420-023-01542-7
Ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer: a comparative bibliometric analysis